Ignite Creation Date:
2025-12-26 @ 4:03 PM
Ignite Modification Date:
2025-12-30 @ 5:29 AM
Study NCT ID:
NCT05007106
Status:
COMPLETED
Last Update Posted:
2025-08-14
First Post:
2021-08-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-05
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-10
First Submit QC Date:
None
Study First Post Date:
2021-08-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-12
Last Update Post Date:
2025-08-14
Last Update Post Date Type:
ACTUAL